NEOS Investment Management LLC Purchases 19,108 Shares of Zoetis Inc. $ZTS

NEOS Investment Management LLC raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 46.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,670 shares of the company’s stock after acquiring an additional 19,108 shares during the period. NEOS Investment Management LLC’s holdings in Zoetis were worth $8,877,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Brighton Jones LLC increased its holdings in shares of Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after buying an additional 2,978 shares during the period. Empowered Funds LLC increased its stake in Zoetis by 6.2% in the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company’s stock worth $1,859,000 after purchasing an additional 657 shares during the period. Intech Investment Management LLC lifted its position in Zoetis by 17.2% in the first quarter. Intech Investment Management LLC now owns 8,347 shares of the company’s stock valued at $1,374,000 after purchasing an additional 1,224 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in shares of Zoetis by 73.8% during the second quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company’s stock valued at $522,000 after purchasing an additional 1,422 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Zoetis in the second quarter worth approximately $11,104,000. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. KeyCorp started coverage on shares of Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating on the stock. BTIG Research restated a “buy” rating and set a $160.00 price target on shares of Zoetis in a report on Wednesday, December 3rd. Morgan Stanley set a $160.00 price objective on Zoetis in a research report on Thursday, December 18th. Piper Sandler reiterated a “neutral” rating and issued a $135.00 price target (down previously from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. Finally, Weiss Ratings cut shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, January 28th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Zoetis currently has an average rating of “Hold” and a consensus price target of $152.91.

Zoetis Price Performance

ZTS stock opened at $125.45 on Wednesday. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03. The firm has a 50 day moving average price of $124.79 and a 200-day moving average price of $135.06. Zoetis Inc. has a 52-week low of $115.25 and a 52-week high of $177.00. The firm has a market capitalization of $52.96 billion, a price-to-earnings ratio of 20.84, a PEG ratio of 2.12 and a beta of 0.96.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s payout ratio is 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.